Welcome to the International Society for Vaccines

Skip to main content

Connie Schmaljohn


Dr. Connie S. Schmaljohn is currently the Director of the Integrated Research Facility at the National Institute of Allergy and Infectious Diseases (NIAID) in Frederick, Maryland.  Previously, she was Senior Research Scientist for Medical Defense Against Infectious Disease Threats (ST) at USAMRIID and her research involved developing medical countermeasures against highly lethal viruses of military importance. She was instrumental in the discovery of hantaviruses, a previously unknown class of rodent-borne viruses that cause hemorrhagic fever or severe respiratory diseases in humans. In addition, she is a widely recognized pioneer and world expert on DNA vaccines and highly pathogenic viruses. 

Dr. Schmaljohn introduced novel vaccine technologies that led to five clinical trials of first-of-kind recombinant DNA-based vaccines to protect against hemorrhagic fever with renal syndrome and Venezuelan equine encephalitis. She has more than 200 research publications and 21 U.S. and international patents to her credit and is the recipient of numerous scientific awards and honors.

ISV Fellow of the Month
United States